TUMORANTIGENE. = ANTIGENES TUMORAUX.HOFFKEN K; SCHMIDT CG.1978; DTSCHE MED. WOCHR.; DEU; DA. 1978; VOL. 103; NO 30; PP. 1187-1190; BIBL. 43 REF.Article

LAPAROSKOPIE BEI MORBUS HODGKIN = LA LAPAROSCOPIE DANS LA MALADIE DE HODGKINHOFFKEN K; SCHMIDT CG.1976; DTSCHE MED. WSCHR.; DTSCH.; DA. 1976; VOL. 101; NO 21; PP. 814-818; ABS. ANGL.; BIBL. 26 REF.Article

NEUERE ASPEKTE IN DER THERAPIE DES OSTEOSARKOMS = NOUVEAUX ASPECTS DU TRAITEMENT DE L'OSTEOSARCOMEHOFFKEN K; SCHMIDT CG.1976; DTSCHE MED. WSCHR.; DTSCH.; DA. 1976; VOL. 101; NO 7; PP. 251-258; BIBL. 1 P. 1/2Article

HUMAN CHORIONIC GONADOTROPIN (HCG) IN MONITORING THE COURSE OF TESTICULAR TUMOURS.HOFFKEN K; SCHMIDT CG.1976; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 87; NO 1; PP. 37-40; ABS. ALLEM.; BIBL. 15 REF.Article

CHEMOTHERAPY IN STAGE II TESTICULAR TUMOURS. = CHIMIOTHERAPIE DANS LES TUMEURS TESTICULAIRES STADE IIHOFFKEN K; SCHMIDT CG.1976; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 86; NO 1; PP. 103-108; ABS. ALLEM.; BIBL. 17 REF.Article

KLASSIFIKATION UND STADIENEINTEILUNG DER HODENTUMOREN. = CLASSIFICATION ET REPARTITION EN STADES DES TUMEURS TESTICULAIRESHOFFKEN K; SCHMIDT CG.1977; DTSCHE MED. WSCHR.; DTSCH.; DA. 1977; VOL. 102; NO 7; PP. 249-252; BIBL. 24 REF.Article

CLASSIFICAZIONE E SUDDIVISIONE IN STADI DEI TUMORI DEL TESTICOLO. = CLASSIFICATIONS ET SUBDIVISIONS EN STADES DES TUMEURS DU TESTICULEHOFFKEN K; SCHMIDT CG.1977; MINERVA UROL.; ITAL.; DA. 1977; VOL. 29; NO 4; PP. 161-166; BIBL. 24 REF.Article

THERAPIE DER HODENTUMOREN. = TRAITEMENT DES TUMEURS TESTICULAIRESHOFFKEN K; SCHMIDT CG.1977; DTSCHE MED. WSCHR.; DTSCH.; DA. 1977; VOL. 102; NO 8; PP. 292-297; BIBL. 30 REF.Article

ACTIVITY OF SYNGENEIC COMPLEMENT FOR REVEALING ANTIBODY-INDUCED CYTOTOXICITY AGAINST A RAT HEPATOMAPRICE MR; HOFFKEN K; BALDWIN RW et al.1979; TRANSPLANTATION; USA; DA. 1979; VOL. 28; NO 2; PP. 140-143; BIBL. 21 REF.Article

CIRCULATING IMMUNE COMPLEXES IN RATS BEARING CHEMICALLY INDUCED TUMORS. I. SEQUENTIAL DETERMINATION DURING THE GROWTH OF TUMOURS AT VARIOUS BODY SITES.HOFFKEN K; PRICE MR; MCLAUGHLIN PJ et al.1978; INTERNATION. J. CANCER; SWITZ.; DA. 1978; VOL. 21; NO 4; PP. 496-504; ABS. FR.; BIBL. 33 REF.Article

Changes in self-renewal potential of human leukemic cells (K562): a bidirectional stochastic processVON MELCHNER, H; HOFFKEN, K.Journal of cellular physiology. 1985, Vol 123, Num 2, pp 249-256, issn 0021-9541Article

ADRIAMCYN, CYCLOPHOSPHAMID UND FLUOROURACIL IN DER THERAPIE DES METASTASIERENDEN MAMMA-CARCINOMS. = ADRIAMYCINE, CYCLOPHOSPHAMIDE ET FLUOROURACILE DANS LE TRAITEMENT DU CANCER DU SEIN METASTASANTHOFFKEN K; SEEBER S; BOECKER WR et al.1976; Z. KREBSFORSCH. KLIN. ONKOL.; DTSCH.; DA. 1976; VOL. 86; NO 2; PP. 135-145; ABS. ANGL.; BIBL. 1 P. 1/2Article

ZUR THERAPIE DER LYMPHOGRANULOMATOSE DES MAGNENS = A PROPOS DU TRAITEMENT DE LA LYMPHOGRANULOMATOSE GASTRIQUEHOFFKEN K; HORNUNG G; BRUNTSCH U et al.1973; DTSCHE MED. WSCHR.; DTSCH.; DA. 1973; VOL. 98; NO 4; PP. 148-152; ABS. ANGL.; BIBL. 40 REF.Serial Issue

Experience with aromatase inhibitors in the treatment of advanced breast cancerHÖFFKEN, K.Cancer treatment reviews. 1993, Vol 19, pp 37-44, issn 0305-7372, SUPBConference Paper

Retrovirus mediated gene transfer into hemopoietic cellsVON MELCHNER, H; HÖFFKEN, K.Blut. 1988, Vol 57, Num 1, pp 1-5, issn 0006-5242Article

The role of apoptosis in hematologic malignancies and modulation of apoptosis as a new therapeutic approachKLICHE, K.-O; HÖFFKEN, K.Journal of cancer research and clinical oncology. 1999, Vol 125, Num 3-4, pp 226-231, issn 0171-5216Article

Human placental conditioned medium reverses apparent commitment to differentiation of human promyelocytic leukemia cells (HL60)VON MELCHNER, H; HÖFFKEN, K.Blood. 1985, Vol 66, Num 6, pp 1469-1472, issn 0006-4971Article

Commitment to differentiation of human promyelocytic leukemia cells (HL60): an all-or-none event preceded by reversible losses of self-renewal potentialVON MELCHNER, H; HÖFFKEN, K.Journal of cellular physiology. 1985, Vol 125, Num 3, pp 573-581, issn 0021-9541Article

CHEMOTHERAPIE MALIGNER KNOCHENTUMOREN. = CHIMIOTHERAPIE DES TUMEURS OSSEUSES MALIGNESHOFFKEN K; SEEBER S; GALLMEIER WM et al.1977; CHIRURG; DTSCH.; DA. 1977; VOL. 48; NO 4; PP. 274-279; ABS. ANGL.; BIBL. 23 REF.Article

NEUE CHEMOTHERAPIE (ADRIAMYCIN, BLEOMYCIN UND VINCRISTIN) METASTASIERENDER MALIGNER HODENTERATOME = NOUVELLE CHIMIOTHERAPIE (ADRIAMYCINE, BLEOMYCINE ET VINCRISTINE) DES TERATOMES MALINS DU TESTICULE METASTASANTSEEBER S; GALLMEIER WM; HOFFKEN K et al.1975; DTSCHE MED. WSCHR.; DTSCH.; DA. 1975; VOL. 100; NO 24; PP. 1319-1325; ABS. ANGL.; BIBL. 40REF.Article

EN ANGLAISHOFFKEN K; MEREDITH ID; ROBINS RA et al.1977; BRIT. MED. J.; G.B.; DA. 1977; NO 6081; PP. 218-220; BIBL. 19 REF.Article

BEHANDLUNG VON NON-HODGKIN-LYMPHOMEN NIEDRIGER MALIGNITAET MIT GANZKOERPERBESTRAHLUNG UND KOMBINIERTER CHEMOTHERAPIE = TRAITEMENT DES LYMPHOMES NON HODGKINIENS DE FAIBLE MALIGNITE PAR IRRADIATION CORPORELLE TOTALE ET CHIMIOTHERAPIE ASSOCIEEOHL S; BAMBERG M; HOLFELD H et al.1979; BLUT; DEU; DA. 1979; VOL. 38; NO 2; PP. 181-183; ABS. ENG; BIBL. 6 REF.Article

25th German Cancer Congress, 10-14 March 2002, Berlin, Germany: Scientific Proceedings (Abstracts)HÖFFKEN, K; SAYER, H. G; SCHRECKENBERGER, C et al.Journal of cancer research and clinical oncology. 2002, Vol 128, issn 0171-5216, 192 p., SUP1Conference Proceedings

Impaired granulocytic function in patients with acute leukaemia : only partial normalisation after successful remission-inducing treatmentHOFMANN, W.-K; STAUCH, M; HÖFFKEN, K et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 2, pp 113-116, issn 0171-5216Article

Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignanciesKATH, R; HARTMANN, M; HÖFFKEN, K et al.Journal of cancer research and clinical oncology. 1998, Vol 124, Num 5, pp 288-290, issn 0171-5216Article